Article info
PDFNeurological rarities
Opsoclonus–myoclonus syndrome caused by organophosphate poisoning
- Correspondence to Dr Pradeep Ravi, General Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth, Pondicherry 607401, India; rp2093{at}gmail.com
Citation
Opsoclonus–myoclonus syndrome caused by organophosphate poisoning
Publication history
- Accepted November 30, 2022
- First published January 6, 2023.
Online issue publication
May 25, 2023
Article Versions
- Previous version (25 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- ‘Dancing eyes, dancing feet syndrome’ in small cell lung carcinoma
- The opsoclonus–myoclonus syndrome
- Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an ‘unresolved’ mystery
- Postintervention acute opsoclonus myoclonus syndrome
- Recurrent angiosarcoma of scalp with opsoclonus myoclonus syndrome: role of salvage treatment
- Sequential fluctuating paraneoplastic ocular flutter–opsoclonus–myoclonus syndrome and Lambert–Eaton myasthenic syndrome in small-cell lung cancer
- Paraneoplastic overlap syndrome in non-small squamous cell lung carcinoma
- Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective
- Opsoclonus–myoclonus as a manifestation of Lyme disease
- Opsoclonus myoclonus syndrome due to squamous cell carcinoma of the oesophagus